DUOS Launches AI-Informed Platform to Connect Older Adults with Vital Resources
At the HLTH Conference, DUOS is Unveiling a New Product Leveraging Artificial Intelligence to Match…
Month: October 2023
Edge Impulse Debuts Smallest, Most Precise HRV Algorithm, Alongside Other Health-Focused Tools
Innovators in the health space including Know Labs, Oura, Nowatch, Hyfe and SlateSafety use Edge…
Valo Therapeutics Announces Acquisition of Bruker Corporation’s Latest Mass Spectrometer Platform for Tumor Antigen Identification with ValoTx’s PeptiCHIP Technology
Top-of-the-Line Molecular Analytics Instrument with Transformative Sensitivity will enable Rapid Identification of Tumor Antigens HELSINKI,…
Valo Therapeutics Announces Acquisition of Bruker Corporation’s Latest Mass Spectrometer Platform for Tumor Antigen Identification with ValoTx’s PeptiCHIP Technology
Top-of-the-Line Molecular Analytics Instrument with Transformative Sensitivity will enable Rapid Identification of Tumor Antigens HELSINKI,…
GPCR Therapeutics Expands Pipeline into Fibrosis with a Combination Approach Targeting LPA1
SEOUL, Korea and REDWOOD CITY, Calif., Oct. 10, 2023 (GLOBE NEWSWIRE) — GPCR Therapeutics, Inc.,…
GPCR Therapeutics Expands Pipeline into Fibrosis with a Combination Approach Targeting LPA1
SEOUL, Korea and REDWOOD CITY, Calif., Oct. 10, 2023 (GLOBE NEWSWIRE) — GPCR Therapeutics, Inc.,…
Salipro Biotech and Icosagen Launch Antibody Discovery Collaboration
Salipro Biotech and Icosagen announce the initiation of a multi-target collaboration for the discovery and…
Salipro Biotech and Icosagen Launch Antibody Discovery Collaboration
Salipro Biotech and Icosagen announce the initiation of a multi-target collaboration for the discovery and…
Sosei Heptares and PharmEnable Therapeutics Expand Drug Discovery Collaboration
The collaboration combines Sosei Heptares’ leading structure-based drug design platform with PharmEnable’s advanced artificial intelligence-enabled…
Sosei Heptares and PharmEnable Therapeutics Expand Drug Discovery Collaboration
The collaboration combines Sosei Heptares’ leading structure-based drug design platform with PharmEnable’s advanced artificial intelligence-enabled…
Novozymes announce the Executive Leadership Team and organizational structure for the future combined company of Novozymes and Chr. Hansen
October 10, 2023 Please see attachment. Contact information Investor RelationsAnders Mohr Christensen+45 2515 2364dkamc@chr-hansen.com Press…
Novozymes announce the Executive Leadership Team and organizational structure for the future combined company of Novozymes and Chr. Hansen
October 10, 2023 Please see attachment. Contact information Investor RelationsAnders Mohr Christensen+45 2515 2364dkamc@chr-hansen.com Press…
Mydecine Innovations Group Announces Admission to Trading on the AQSE Growth Market in London, UK and First Day of Dealings
VANCOUVER, British Columbia, Oct. 10, 2023 (GLOBE NEWSWIRE) — Mydecine Innovations Group, Inc. (“Mydecine” or…
Mydecine Innovations Group Announces Admission to Trading on the AQSE Growth Market in London, UK and First Day of Dealings
VANCOUVER, British Columbia, Oct. 10, 2023 (GLOBE NEWSWIRE) — Mydecine Innovations Group, Inc. (“Mydecine” or…
Executive Leadership Team and organizational structure announced for the future combined company of Novozymes and Chr. Hansen
Read the full announcement in PDF Attachment 2023_57_Executive_Leadership_Team
Executive Leadership Team and organizational structure announced for the future combined company of Novozymes and Chr. Hansen
Read the full announcement in PDF Attachment 2023_57_Executive_Leadership_Team
AstriVax Strengthens Leadership Team by Welcoming Chief Development Officer (CDO) Dr. Mathieu Peeters and Chief Financial Officer (CFO) Barbara Freitag
Dr. Mathieu Peeters brings an extensive clinical vaccine development track record from his senior roles…
AstriVax Strengthens Leadership Team by Welcoming Chief Development Officer (CDO) Dr. Mathieu Peeters and Chief Financial Officer (CFO) Barbara Freitag
Dr. Mathieu Peeters brings an extensive clinical vaccine development track record from his senior roles…
Roche’s Vabysmo maintained vision improvements with extended treatment intervals up to four months for people with retinal vein occlusion (RVO) in phase III studies
Vabysmo showed robust and sustained retinal drying up to 72 weeks and a safety profile…
CloudAEye Transforms Log Management with Latest Breakthrough of AI
CloudAEye Launches Semantic Observability Solution with AI-Powered Log Management FREMONT, Calif., Oct. 10, 2023 (GLOBE…